Company Profile

-

Latest News

Ipsen’s Bylvay fails in Phase III biliary atresia study

Clinical Trials Arena • 07/27/2026

Rothschild & Co Redburn Adjusts PT on Honeywell International to $216 From $214, Keeps Neutral Rating

MT Newswires • 07/27/2026

JPMorgan Adjusts PT on Honeywell International to $262 From $250, Maintains Overweight Rating

MT Newswires • 07/27/2026

Jefferies Adjusts Price Target on Teledyne Technologies to $830 From $775, Maintains Buy Rating

MT Newswires • 07/27/2026

Goldman Sachs Adjusts PT on Teledyne Technologies to $877 From $858, Maintains Buy Rating

MT Newswires • 07/27/2026